Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-005820)

Filing Details

Accession Number:: 0001179110-18-005820
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-23 16:56:18
Reporting Period:: 2018-04-19

Accepted Time:: 2018-04-23 16:56:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229450	A Craig Wheeler	C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-04-19	900	$10.43	198,479	No	4	M	Direct
Common Stock	Disposition	2018-04-19	900	$21.00	197,579	No	4	S	Direct
Common Stock	Disposition	2018-04-19	4,996	$21.00	354,649	No	4	S	Indirect	Craig Wheeler Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	Craig Wheeler Revocable Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-04-19	900	$0.00	900	$10.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,766	2013-02-25	2019-02-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	45,980	Indirect	Craig A Wheeler 2016 Annuity Trust

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2016.